EWTX · Company research
Edgewise Therapeutics, Inc. (EWTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history - Yahoo Finance UK | Edgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 16, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 9, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history - Yahoo Finance Australia | Edgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 8, 2026 | neutral | 0 | 0.6 |
| A quarterly stock award gives director Fox 308 shares of Edgewise Therapeutics (EWTX). - Stock Titan | A quarterly stock award gives director Fox 308 shares of Edgewise Therapeutics (EWTX). Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Edgewise screened more than 7,000 candidates for a heart treatment. EDG-7500 improved relaxation in early tests. - Stock Titan | Edgewise screened more than 7,000 candidates for a heart treatment. EDG-7500 improved relaxation in early tests. Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics (EWTX) Is Up 6.6% After Wider Q2 Losses Highlight Rising Spend - Has The Bull Case Changed? - Simply Wall Street | Edgewise Therapeutics (EWTX) Is Up 6.6% After Wider Q2 Losses Highlight Rising Spend - Has The Bull Case Changed? Simply Wall Street | View source ↗ | Simply Wall Street | Aug 20, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics: Servier Deal Creates A Self-Funded Cardiovascular Platform (EWTX) - Seeking Alpha | Edgewise Therapeutics: Servier Deal Creates A Self-Funded Cardiovascular Platform (EWTX) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 18, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics (EWTX) GC nets RSU vesting, tax sales and new grants - Stock Titan | Edgewise Therapeutics (EWTX) GC nets RSU vesting, tax sales and new grants Stock Titan | View source ↗ | Stock Titan | Aug 14, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics gains as investors weigh cash-rich reset and cardiovascular pipeline progress - Quiver Quantitative | Edgewise Therapeutics gains as investors weigh cash-rich reset and cardiovascular pipeline progress Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 4, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics Stock Rides A 5-Day Winning Streak To A 23% Gain - Trefis | Edgewise Therapeutics Stock Rides A 5-Day Winning Streak To A 23% Gain Trefis | View source ↗ | Trefis | Jul 10, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics stock tumbles 25% on trial data - Investing.com | Edgewise Therapeutics stock tumbles 25% on trial data Investing.com | View source ↗ | Investing.com | Jun 16, 2026 | neutral | 0 | 0.6 |
| Biotech Whips Violently Between Red And Green — What's Going On? - Investor's Business Daily | Biotech Whips Violently Between Red And Green — What's Going On? Investor's Business Daily | View source ↗ | Investor's Business Daily | Jun 16, 2026 | neutral | 0 | 0.6 |
| Leerink reiterates Edgewise Therapeutics stock rating on trial data - Investing.com | Leerink reiterates Edgewise Therapeutics stock rating on trial data Investing.com | View source ↗ | Investing.com | Jun 16, 2026 | neutral | 0 | 0.6 |
| EWTX Stock Hits Record High – Why Servier Is Shelling Out $2.65B For Edgewise’s Muscular Dystrophy Business - Stocktwits | EWTX Stock Hits Record High – Why Servier Is Shelling Out $2.65B For Edgewise’s Muscular Dystrophy Business Stocktwits | View source ↗ | Stocktwits | Jun 1, 2026 | neutral | 0 | 0.6 |
| CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits | CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? Stocktwits | View source ↗ | Stocktwits | May 5, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics Stock Climbs On Catalyst-Rich Pipeline - timothysykes.com | Edgewise Therapeutics Stock Climbs On Catalyst-Rich Pipeline timothysykes.com | View source ↗ | timothysykes.com | May 5, 2026 | neutral | 0 | 0.6 |
| Edgewise Therapeutics, Inc. Common Stock (EWTX) Stock Price: Oct 8 Close $39.23 - Gotrade | Edgewise Therapeutics, Inc. Common Stock (EWTX) Stock Price: Oct 8 Close $39.23 Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.